Royalties Payments. 3.1 LICENSEE shall make:
(a) royalty payments to LICENSOR for each royalty bearing copy of the Run-Time Software shipped hereunder by LICENSEE or distributed by any Third Party pursuant to Addendum B.
(b) payments for Technical Support to LICENSOR pursuant to Addendum B.
3.2 LICENSEE shall provide LICENSOR with calendar quarterly reports showing the quantity of Designated Equipment shipped or otherwise transferred to an End User by LICENSEE or Third Parties hereunder, as well as the gross revenue received by LICENSEE, commencing after the commercial release of the Designated
Royalties Payments. 2.1 Bioenvision shall pay to Stegram a royalty of 10% of net sale price for product sold directly by Bioenvision or any of its subsidiaries. Net sale price is defined as the total sale price charged by Bioenvision or its subsidiaries minus discounts and tax. After expiry of the last patent a royalty of 5% of net sales shall be payable so long as Bioenvision uses any Trademarks owned by Stegram.
2.2 If Bioenvision shall transfer rights acquired under the Agreement to a third party other than a subsidiary of Bioenvision any payments received, including mile-stone payments and royalties, shall be divided equally between the parties after deduction of development costs incurred by Bioenvision.
2.3 Bioenvision shall transfer to Stegram 100,000 shares in Bioenvision, Inc. within ninety (90) days of signing the definitive Agreement.
2.4 After three (3) years of the date of the definitive Agreement Bioenvision agrees to pay a minimum royalty of $50,000 per year. If sales of the Product(s) are not sufficient to meet the minimum royalty Bioenvision shall have the right to offset any excess payment against future royalties for up to two (2) years after the minimum royalty becomes payable.
2.5 Bioenvision shall purchase the existing stocks or Product and raw material and pharmaceutically prepared forms of the product from Stegram, provided they are in a good and stable condition and suitable to meet regulatory requirements for the sale or manufacture of pharmaceutical products. Thereafter Bioenvision shall be responsible for the manufacture of the raw material and pharmaceutical dose forms.
Royalties Payments. Lessee shall pay to Lessor, a four percent (4%) gross production royalty from the sale or disposition of minerals, metal and materials taken from “The Property” leased to Lessee and covered by this Lease. All payments made under this agreement shall be made to Lessor by Lessee within fifteen (15) days from that date that the buyer makes final settlement with Lessee. Payments shall be made either in person or to the address under which Lessor enters this agreement. Payment made to the Lessor shall be accompanied by the sales slip showing the basis upon which the sale has been made. All settlement sheets or sales slips shall be marked as sold from “The Property”. In consideration for this Lease, Lessee will pay Lessor $1000 upon signing, $5,000 March 15th 2004 and a minimum annual royalty of $6,000 Jan 1st 2005, $8,000 Jan 1st 2006, $10,000 Jan 1st 2007, $12,000 Jan 1st 2008 and $12,000 Jan 1st every year there after as long as this Lease is in effect. All minimum annual royalties shall be applied to actual royalties.
Royalties Payments. 6.1 Licensee will pay to Monash earned royalties based on aggregate Net Sales of Licensed Products in the Licensed Territory by or on behalf of Licensee, its Affiliates, and its Sublicensees (as applicable) in a given Calendar Year during the Royalty Term, on an incremental percentage basis as set forth below: [***] [***] [***] [***] For clarity, the royalty rates set forth in the table in this Section 6.1 are intended to be applied incrementally, with the specified royalty rate applying to the portion of Net Sales in the Licensed Territory in a given Calendar Year that fall within the range to which such royalty rate applies. Royalties will be payable on a Licensed Product-by-Licensed Product and country-by-country basis until the expiry of the Royalty Term for such Licensed Product in such country. Any royalties paid by Licensee to Monash under this Section 6.1 during a Calendar Year shall be creditable against any Annual License Maintenance Fee described in Section 5.2 for such Calendar Year.
6.2 In the event that, on a country-by-country and Licensed Product-by-Licensed Product basis, no Valid Claim under any Monash Patent Rights covers the [***] of such Licensed Product in such country, the royalties due during the Royalty Term pursuant to Section 6.1 with respect to such Licensed Product in such country will be reduced by [***].
6.3 If Licensee, in its reasonable judgment, determines that it is required to obtain a license from any Third Party under such Third Party's intellectual property rights that are relevant to the development, manufacture, use or sale of the Licensed Products in connection with Licensee’s exercise of its rights under Section 3.1 of this Agreement, and Licensee is required to pay such Third Party [***] (“Third Party Compensation”), then the amount that would otherwise have been payable as royalties under Section 6.1 herein shall be reduced by [***] to such Third Party Compensation payable by or on behalf of Licensee during such period; provided, that in no event will the reduction described in this Section 6.3 act to reduce the royalties payable by Licensee to Monash to less than [***] of the royalties payable pursuant to Section 6.1 in a given Calendar Quarter. If any amount of such available reduction as described in this Section 6.3 is not fully credited against royalties due to Licensee during a Calendar Quarter, such amount shall be carried forward and creditable in subsequent Calendar Quarters.
6.4 Royalties payable under...
Royalties Payments. No specific royalties shall be due under this Agreement for the grant of the License; however, the Parties hereby agree to supply the other Party’s reasonable requirements of Products for the pre-determined price. The Parties hereby agree that each Party shall maintain the exclusive right to manufacture its Product, and the Licensee shall purchase all EDCI Products exclusively from Licensor. Licensor shall purchase all BGF Products exclusively from Licensee. All other equipment required for construction and operation of a Project utilizing the Technology may be purchased from other vendors.
Royalties Payments. After receiving the Statement, ChromaDex shall submit an invoice to NHSc in the amount indicated on the Statement and NHSc shall pay such invoice within [***] of the invoice date.
Royalties Payments. 4.1 In consideration of the license granted to ITAWASH under Article 2 for the Products, ITAWASH agrees to pay to CHINA MIX a royalty (hereinafter “the Royalty”) of (a) 1,25 Euros for any and each ITAWASH Made Product sold by ITAWASH as from the date of execution of this agreement as well as (b) 1,25 Euros for any and each Third Party Made Product purchased by ITAWASH from the Third Party Manufacturer as from the date of execution of this agreement.
4.2 Payment of the Royalty shall be made by ITAWASH to CHINA MIX as follows: (a) ITAWASH agrees to provide written reports comprising the product codes to CHINA MIX within thirty (30) days after the first of January, April, July and October of each calendar year stating in each such report the quantity of Products invoiced with respect to ITAWASH Made Products sold by ITAWASH and/or the quantity of Products invoiced with respect to Third Party Made Products purchased by ITAWASH from the Third Party Manufacturer during the preceding quarter and the total amount of Royalty payable therefore.
Royalties Payments. STOCK AND REIMBURSEMENT --------------------------------------------
Royalties Payments. 3.1. Royalties In consideration for the rights granted under Article II, except as provided in Article VI hereof, LICENSEE shall make royalty payments to LICENSOR for the Run-Time Software, pursuant to Addendum C.
3.2. Other Fees Any training provided by LICENSOR under this Agreement will be invoiced at the end of each month in which said services are provided at the then current fees. Unless otherwise provided in writing, all invoices are payable within thirty (30) days after invoice date.
Royalties Payments. 3.1. Royalties In consideration for the rights granted under Article II, LICENSEE shall make royalty payments to LICENSOR, pursuant to Addendum C, for the Run-Time Software shipped hereunder by LICENSEE or distributed by any Third Party.
